Informações de Emergent BioSolutions Inc

Mais detalhes de Emergent BioSolutions Inc Empresa

Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a Bioservices portfolio. Its segments include Commercial Products, MCM Products, and Services Segment. Commercial Products segment include NARCAN (naloxone HCl). MCM Products segment consists of its Anthrax - MCM, Smallpox - MCM and Other Products. Services segment consisting of its Bioservices offerings. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression. Its portfolio of Bioservices consists of three but interrelated service pillars, such as development services (process and analytical development) and drug substance manufacturing.



Código da empresaEBS

Nome da EmpresaEmergent BioSolutions Inc

Data de listagemNov 15, 2006

CEOMr. Joseph C. (Joe) Papa

Número de funcionários900

Tipo de títulosOrdinary Share

Fim do ano fiscalNov 15

Endereço300 Professional Dr

CidadeGAITHERSBURG

Bolsa de valoresNYSE Consolidated

PaísUnited States of America

Código postal20879

Telefone12406313200

Sitehttps://emergentbiosolutions.com/

Código da empresaEBS

Data de listagemNov 15, 2006

CEOMr. Joseph C. (Joe) Papa

Executivos da empresa Emergent BioSolutions Inc



Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Joseph C. (Joe) Papa

President, Chief Executive Officer, Director

342.50K

+21.24%

Mr. Richard S. (Rich) Lindahl

Chief Financial Officer, Executive Vice President, Treasurer

196.50K

-2.48%

The Hon. Dr. Louis W. Sullivan, M.D.

Independent Director

118.86K

+40.74%

Dr. Zsolt Harsanyi, Ph.D.

Independent Chairman of the Board

103.49K

+49.80%

Dr. Simon C Lowry, M.D.

Chief Medical Officer, Head of Research and Development

91.98K

+211.99%

Ms. Coleen Glessner

Executive Vice President - Quality and Ethics and Compliance

90.86K

-25.20%

Mr. Ronald B. Richard

Independent Director

85.27K

+67.63%

Ms. Jessica Perl

Senior Vice President, General Counsel, Corporate Secretary

68.39K

+1061.66%

Mr. Marvin L. White

Independent Director

68.25K

+101.64%

Mr. Keith A. Katkin, CPA

Independent Director

66.14K

-10.60%

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Joseph C. (Joe) Papa

President, Chief Executive Officer, Director

342.50K

+21.24%

Mr. Richard S. (Rich) Lindahl

Chief Financial Officer, Executive Vice President, Treasurer

196.50K

-2.48%

The Hon. Dr. Louis W. Sullivan, M.D.

Independent Director

118.86K

+40.74%

Dr. Zsolt Harsanyi, Ph.D.

Independent Chairman of the Board

103.49K

+49.80%

Dr. Simon C Lowry, M.D.

Chief Medical Officer, Head of Research and Development

91.98K

+211.99%

Ms. Coleen Glessner

Executive Vice President - Quality and Ethics and Compliance

90.86K

-25.20%

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por EmpresaUSD

Nome

Receita

Proporção

Commercial Product sales

67.50M

47.91%

MCM Product sales

58.40M

41.45%

Contracts and grants

15.00M

10.65%

Por RegiãoUSD

Nome

Receita

Proporção

Non-U.S Government

83.10M

58.98%

U.S.Government

57.80M

41.02%

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Commercial Product sales

67.50M

47.91%

MCM Product sales

58.40M

41.45%

Contracts and grants

15.00M

10.65%

Distribuição de ações

Atualizado em: qui, 16 de out

Investidores

Tipos de investidores

Investidores

Proporção

BlackRock Institutional Trust Company, N.A.

7.29%

The Vanguard Group, Inc.

6.74%

American Century Investment Management, Inc.

4.36%

Dimensional Fund Advisors, L.P.

3.52%

State Street Investment Management (US)

3.31%

Outro

74.77%

Investidores

Proporção

BlackRock Institutional Trust Company, N.A.

7.29%

The Vanguard Group, Inc.

6.74%

American Century Investment Management, Inc.

4.36%

Dimensional Fund Advisors, L.P.

3.52%

State Street Investment Management (US)

3.31%

Outro

74.77%

Tipos de investidores

Investidores

Proporção

Investment Advisor

32.25%

Investment Advisor/Hedge Fund

25.29%

Hedge Fund

9.57%

Individual Investor

3.05%

Research Firm

2.97%

Pension Fund

1.05%

Bank and Trust

0.84%

Sovereign Wealth Fund

0.18%

Venture Capital

0.05%

Outro

24.74%

Participação acionária institucional



Atualizado em: qua, 1 de out

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q3

404

37.65M

71.69%

-6.17M

2025Q2

444

39.60M

73.05%

-8.24M

2025Q1

472

38.22M

70.45%

-8.61M

2024Q4

475

36.31M

66.90%

-8.91M

2024Q3

485

33.46M

61.86%

-11.26M

2024Q2

503

32.16M

60.76%

-21.31M

2024Q1

512

37.52M

71.59%

-17.68M

2023Q4

531

43.49M

83.79%

-11.00M

2023Q3

581

43.88M

84.66%

-15.71M

2023Q2

596

48.59M

93.79%

-8.52M

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

BlackRock Institutional Trust Company, N.A.

3.83M

7.18%

+2.25M

+141.83%

Jun 30, 2025

The Vanguard Group, Inc.

3.58M

6.72%

+370.21K

+11.52%

Jun 30, 2025

American Century Investment Management, Inc.

2.29M

4.3%

-5.46K

-0.24%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

1.85M

3.47%

+252.40K

+15.81%

Jun 30, 2025

State Street Investment Management (US)

1.74M

3.26%

+30.01K

+1.75%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.28M

2.4%

+666.71K

+108.89%

Jun 30, 2025

Oak Hill Advisors, L.P.

1.11M

2.09%

--

Jun 30, 2025

Charles Schwab Investment Management, Inc.

1.11M

2.07%

+521.91K

+89.48%

Jun 30, 2025

Palisade Capital Management, LLC

1.10M

2.06%

-41.83K

-3.66%

Jun 30, 2025

Marshall Wace LLP

1.02M

1.91%

-139.01K

-12.01%

Jun 30, 2025

Ver Mais

ETFs Relacionados



Atualizado em: qui, 6 de nov

Nome

Proporção

Royce Quant Small-Cap Quality Value ETF

0.31%

SPDR S&P Biotech ETF

0.21%

Federated Hermes MDT Small Cap Core ETF

0.18%

Harbor Human Capital Factor US Small Cap ETF

0.13%

Pacer US Small Cap Cash Cows ETF

0.12%

Invesco RAFI US 1500 Small-Mid ETF

0.12%

Direxion Daily S&P Biotech Bull 3X Shares

0.11%

Avantis US Small Cap Value ETF

0.1%

iShares Micro-Cap ETF

0.09%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.09%

Ver Mais

Royce Quant Small-Cap Quality Value ETF

Proporção0.31%

SPDR S&P Biotech ETF

Proporção0.21%

Federated Hermes MDT Small Cap Core ETF

Proporção0.18%

Harbor Human Capital Factor US Small Cap ETF

Proporção0.13%

Pacer US Small Cap Cash Cows ETF

Proporção0.12%

Invesco RAFI US 1500 Small-Mid ETF

Proporção0.12%

Direxion Daily S&P Biotech Bull 3X Shares

Proporção0.11%

Avantis US Small Cap Value ETF

Proporção0.1%

iShares Micro-Cap ETF

Proporção0.09%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

Proporção0.09%

Dividendo



Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações



Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados